The Best in Drugs and Biotech

The Best in Drugs and Biotech: “S&P’s Herman Saftlas and Frank DiLorenzo share some favorites in these resurgent sectors, including Barr Pharmaceuticals and MedImmune “

0 Comments/

0 Likes

/0 Tweets/in General Biotechnology

September 18, 2003

18 Sep 2003

What VCs Don't Tell You

What VCs Don’t Tell You: “To secure funding, an entrepreneur needs to appreciate the goals and strategies at work on the other side the table. Here’s a guide “

0 Comments/

0 Likes

/0 Tweets/in General Biotechnology

September 11, 2003

11 Sep 2003

Building a Better R&D Mousetrap

Building a Better R&D Mousetrap: “By posting their scientific conundrums online, companies like Eli Lilly and Procter & Gamble have discovered a rich new source of brainpower.”

0 Comments/

0 Likes

/0 Tweets/in General Biotechnology

September 2, 2003

02 Sep 2003

A WTO deal on drugs

A WTO deal on drugs
India and Brazil are good at making cheap copies of life-saving drugs. Now they are allowed to export them too…

0 Comments/

0 Likes

/0 Tweets/in General Biotechnology

August 7, 2003

07 Aug 2003

Biotechs big winners in VC rebound

Biotechs big winners in VC rebound

Biotechnology companies are leading a rebound in venture capital investment in the New York metro area, a new survey shows.

Investors put $380 million into 56 companies in the second quarter of this year, for a 63% jump in venture capital investment over the first quarter, according to the MoneyTree Survey by PricewaterhouseCoopers, Thomson Venture Economics and the National Venture Capital Association.